Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury

• Status: Unknown status
• Trial end date: 2019-12-31
• Target enrollment: 0
• Participant gender: All

Summary

A randomized, double-blind, placebo-controlled, parallel, multi-center phase III clinical trial

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Daewon Pharmaceutical Co., Ltd.

Criteria

Inclusion Criteria:

• Adult patient, ages over 19 years

• Patients with post traumatic acute pain within 48 hr(sprain/strain)

• Patient whose pain scale is over 50 mm(VAS score)

Exclusion Criteria:

• Patients with chronic pain

• Presence of a fracture or more than one injury

• Previous adverse reaction or known allergy to NSAIDs